Table 1.
n = 55 | ||
---|---|---|
Age (years), M (SD) | 39.6 (14.3) | |
Sex, % (n) | Male | 94.5% (52) |
Female | 5.5% (3) | |
Ethnicity, % (n) | White | 50.9% (28) |
Black | 16.4% (9) | |
Asian | 7.3% (4) | |
First Nations | 3.6% (2) | |
Middle Eastern | 3.6% (2) | |
Mixed Heritage | 3.6% (2) | |
Latin American | 1.8% (1) | |
Not provided | 12.7% (7) | |
Security level, % (n) | Medium | 12.7% (7) |
High | 87.3% (48) | |
Anti-psychotic dose (CPZ equiv.), M (SD) | 600 (525) | |
Diagnosed disorder, % (n) | Psychotic | 76.8% (43) |
Anxiety | 7.1% (4) | |
Personality | 39.3% (22) | |
Substance use | 53.6% (30) | |
Neurodevelopmental | 19.6% (11) | |
Sexual | 10.7% (6) | |
Other | 1.8% (1) | |
Index offense, % (n) | Murder or attempted murder | 28.6% (16) |
Physical assault | 51.8% (29) | |
Verbal assault | 32.1% (18) | |
Sexual offenses | 14.3% (8) | |
Reckless endangerment | 10.7% (6) | |
Length of stay (years), M (SD) | 5.3 (9.5) | |
BPAQ-SF, M (SD) | Physical aggression | 6.2 (3.1) |
Verbal aggression | 7.1 (3.7) | |
Anger | 6.7 (3.4) | |
Hostility | 8.1 (3.8) | |
SD3, M (SD) | Machiavellianism | 3.0 (0.6) |
Narcissism | 3.1 (0.6) | |
Psychopathy | 2.5 (0.6) |
CPZ equiv., daily scheduled intake of anti-psychotic medication in chlorpromazine equivalents; Cumulative diagnosed disorder and index offense are greater than 100% due to the presence of comorbidity and multiple offenses per participant; BPAQ-SF, Buss Perry Aggression Questionnaire—Short Form; SD3, Short Dark Triad Questionnaire.